SRI/Surgical Express Logo

Synergy Health Successfully Completes Tender Offer for Shares of Common Stock of SRI/Surgical Express, Inc.

| Source: SRI/Surgical Express, Inc.

SWINDON, United Kingdom and TAMPA, Fla., July 13, 2012 (GLOBE NEWSWIRE) -- Synergy Health plc (LSE:SYR) and SRI/Surgical Express, Inc. (Nasdaq:STRC) ("SRI") today announced the successful completion of the tender offer by Synergy Health plc's wholly-owned subsidiary in the United States, SHM Acquisition, Inc. ("Purchaser"), to purchase all outstanding shares of common stock of SRI for $3.70 per share, net to the seller in cash, without interest and less any required withholding taxes. The tender offer expired at 12:00 midnight, New York City time, on Thursday, July 12, 2012 and was not extended.

Based on preliminary information from the depositary for the tender offer, shareholders of SRI had tendered and not withdrawn 5,365,901 shares of SRI common stock (including 137,204 shares tendered pursuant to the guaranteed delivery procedures), which represent approximately 82.7% of the outstanding shares on a fully diluted basis (other than the restricted stock awards and company stock options of SRI which SRI has cancelled and is in the process of cashing out). Purchaser has accepted for payment all validly tendered shares and will promptly make payment to the depositary for the accepted Shares.

Synergy Health plc also announced that as at least 80% of SRI's outstanding shares were validly tendered, Synergy Health plc's wholly owned subsidiary, Synergy Health US Holdings Limited ("Parent"), and Purchaser are able to effect a short-form merger in accordance with Florida law. Parent and Purchaser intend to effect a short-form merger of Purchaser with SRI as promptly as practicable, without the need for a meeting of SRI's shareholders. As a result of the merger, the remaining SRI shareholders who did not tender their shares in the tender offer will receive the same $3.70 per share price, without interest and subject to any required withholding taxes, that was paid in the tender offer. After the merger, SRI will be a wholly-owned subsidiary of Parent and SRI shares will cease to be traded on NASDAQ. SRI shareholders who did not tender their shares in the tender offer will receive relevant information in the mail on how to receive payment for their shares in connection with the merger.

About Synergy Health plc

Synergy Health plc is a global leader in outsourced sterilization services to the medical device market as well as to hospitals and other healthcare providers. In addition, the business provides other outsourced services such as healthcare linen, pathology and specialist laboratory services. The business operates across health related markets in the UK & Ireland, Europe & the Middle East, Asia & Africa and the Americas. For more information, please visit

About SRI/Surgical Express, Inc.

SRI ( provides central processing and supply chain management services to hospitals and surgery centers across the United States. SRI serves hospitals and surgery centers in 25 states from 10 reprocessing facilities and four distribution centers located throughout the United States.

The SRI/Surgical Express, Inc. logo is available at

Forward Looking Statements

This press release contains statements that are forward-looking and are subject to risks and uncertainties that could cause actual results to materially differ from those described. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including all statements and information regarding the intent, belief or current expectation of Synergy Health plc, Purchaser, SRI and members of their respective senior management teams. All forward-looking statements are based largely on current expectations and beliefs concerning future events, approvals and transactions that are subject to substantial risks and uncertainties. Factors that may cause or contribute to the actual results or outcomes being different from those contemplated by forward-looking statements include: uncertainties as to the timing of the tender offer; uncertainties as to how many of SRI's shareholders will tender their shares in the offer; the possibility that competing offers will be made; the possibility that various closing conditions for the transactions may not be satisfied or waived, including that a governmental or regulatory authority may prohibit or delay the consummation of the transactions; the effects of disruption from the proposed transactions making it more difficult to maintain relationships with employees, customers and/or other business relationships; other business effects, including the effects of industry, regulatory, economic and/or market conditions that are outside of Synergy Health plc's, Purchaser's or SRI's control; unexpected transaction costs and actual or contingent liabilities; and other risks and uncertainties discussed in documents filed by SRI with the U.S. Securities and Exchange Commission (the "SEC"), including, but not limited to, SRI's reports on Forms 10-Q, 10-K, and 8-K that it periodically files with the SEC, and the Tender Offer Statement on Schedule TO and Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC in connection with the tender offer. These factors include SRI's sales process and market acceptance of its products and services, SRI's capital needs, SRI's dependence on significant customers and suppliers, risks of a new product offering, risks that SRI may incur significant costs related to self-insurance retention levels for employee benefits and workers' compensation programs, and the competitive healthcare marketplace. Neither Synergy Health plc nor SRI undertakes any obligation to update any forward-looking statements as a result of new information, future developments or otherwise, except as expressly required by law.

Media/Investor Contacts

For Synergy Health plc:

Dr Richard Steeves, Chief Executive
Gavin Hill, Finance Director
+44 1793 891891

For SRI/Surgical Express, Inc.:

Stan Berger or Andrew Berger
SM Berger & Company, Inc.
(216) 464-6400